David C. Myles
CH. DISCOV. & NON-CLIN DEV OFF · Olema Pharmaceuticals, Inc.
- 2024
- Feb 5, 2026
- 3
Summary
Latest filing:
David C. Myles is CH. DISCOV. & NON-CLIN DEV OFF of Olema Pharmaceuticals, Inc. (OLMA). 3 SEC Form 4 filings on record going back to 2024, most recently on 5 February 2026. Most recent open-market trade: sold $1.01M of OLMA on 15 January 2026. Lifetime open-market sales: $3.34M.
Recent transactions
11The latest 11 SEC Form 4 transactions reported by David C. Myles.
Trading pattern
InsiderAlpha's records for David C. Myles go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David C. Myles files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shane William Charles Kovacs - $2.98M in OLMA purchases and sales in the last 12 months
- Shawnte Mitchell - $952K in OLMA purchases and sales in the last 12 months
- Cyrus Harmon - $662K in OLMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David C. Myles?
David C. Myles is a corporate insider, tracked as CH. DISCOV. & NON-CLIN DEV OFF of Olema Pharmaceuticals, Inc. (OLMA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David C. Myles last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 3 filings going back to 2024.
Has David C. Myles been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($3.34M) across all tracked filings.